These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28689374)

  • 1. Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.
    Hu S; Leblanc AF; Gibson AA; Hong KW; Kim JY; Janke LJ; Li L; Vasilyeva A; Finkelstein DB; Sprowl JA; Sweet DH; Schlatter E; Ciarimboli G; Schellens J; Baker SD; Pabla N; Sparreboom A
    Clin Transl Sci; 2017 Sep; 10(5):412-420. PubMed ID: 28689374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism.
    Neamatallah T; El-Shitany N; Abbas A; Eid BG; Harakeh S; Ali S; Mousa S
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32630784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
    Wen S; Wang C; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Liu K
    Toxicol Lett; 2018 Oct; 295():195-204. PubMed ID: 29964132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.
    Nagle MA; Truong DM; Dnyanmote AV; Ahn SY; Eraly SA; Wu W; Nigam SK
    J Biol Chem; 2011 Jan; 286(1):243-51. PubMed ID: 20921221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Parvez MM; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression and function of Oat1 and Oat3 in rat kidney exposed to mercuric chloride.
    Di Giusto G; Anzai N; Ruiz ML; Endou H; Torres AM
    Arch Toxicol; 2009 Oct; 83(10):887-97. PubMed ID: 19533102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
    Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
    Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
    Bush KT; Wu W; Lun C; Nigam SK
    J Biol Chem; 2017 Sep; 292(38):15789-15803. PubMed ID: 28765282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1.
    Koh AS; Simmons-Willis TA; Pritchard JB; Grassl SM; Ballatori N
    Mol Pharmacol; 2002 Oct; 62(4):921-6. PubMed ID: 12237339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human organic anion transporter 2 is distinct from organic anion transporters 1 and 3 with respect to transport function.
    Henjakovic M; Hagos Y; Krick W; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2015 Nov; 309(10):F843-51. PubMed ID: 26377792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs.
    Iwaki M; Shimada H; Irino Y; Take M; Egashira S
    Biol Pharm Bull; 2017; 40(6):926-931. PubMed ID: 28566636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
    Granados JC; Richelle A; Gutierrez JM; Zhang P; Zhang X; Bhatnagar V; Lewis NE; Nigam SK
    J Biol Chem; 2021; 296():100575. PubMed ID: 33757768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
    Nagle MA; Wu W; Eraly SA; Nigam SK
    Neurosci Lett; 2013 Feb; 534():133-8. PubMed ID: 23196129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human organic anion transporter OAT1 is not responsible for glutathione transport but mediates transport of glutamate derivatives.
    Hagos Y; Burckhardt G; Burckhardt BC
    Am J Physiol Renal Physiol; 2013 Feb; 304(4):F403-9. PubMed ID: 23255614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats.
    Schneider R; Sauvant C; Betz B; Otremba M; Fischer D; Holzinger H; Wanner C; Galle J; Gekle M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1599-605. PubMed ID: 17244891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal expression of organic anion transporters is modified after mercuric chloride exposure: Gender-related differences.
    Hazelhoff MH; Bulacio RP; Chevalier A; Torres AM
    Toxicol Lett; 2018 Oct; 295():390-396. PubMed ID: 30031051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats.
    Liu T; Meng Q; Wang C; Liu Q; Guo X; Sun H; Peng J; Ma X; Kaku T; Liu K
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):423-30. PubMed ID: 22992436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.